Scarica l'app Stockscreener
76.89
0.08%
0.06
Dopo l'orario di chiusura:
76.86
-0.03
-0.04%
Forte Biosciences Inc Borsa (FBRX) Ultime notizie
Forte Biosciences (NASDAQ:FBRX): What Will the Market Learn About Development Strategy? - Kalkine Media
Avoiding Lag: Real-Time Signals in (FBRX) Movement - Stock Traders Daily
How Investors Are Reacting To Forte Biosciences (FBRX) Widening Losses But Slightly Improved Per-Share Results - simplywall.st
Forte Biosciences, Inc. (NASDAQ:FBRX) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Forte Biosciences earnings on deck as $2.2 billion argenx deal nears - Investing.com Canada
Barclays Maintains Forte Biosciences(FBRX.US) With Hold Rating, Maintains Target Price $77 - Moomoo
Forte Biosciences (FBRX) gains 5.6% stake holder in Affinity Asset Advisors - Stock Titan
Argenx stock holds near recent highs as half year 2026 update and Forte deal shape outlook - AD HOC NEWS
FBRX SWOT Analysis: Financial Challenges and Growth Potential Re - GuruFocus
FORTE BIOSCIENCES ($FBRX) Releases Q2 2026 Earnings - Quiver Quantitative
Forte Biosciences Announces Q2 2026 Financial Results Highlighting Increased R&D and Successful Equity Raise - Kalkine Media
Forte Biosciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Forte Biosciences (NASDAQ:FBRX) Releases Earnings Results, Misses Estimates By $0.09 EPS - MarketBeat
Forte Biosciences (FBRX) to be acquired by argenx in $77-per-share cash deal - Stock Titan
Forte Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Forte Biosciences (FBRX) investor Glazer Capital now holds 1.46% stake - Stock Titan
Hedge Funds Favor argenx (ARGX) Over Forte Biosciences, Inc. (FBRX): Argenx Agrees to Buy Forte Biosciences - Yahoo Finance
Forte Biosciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Forte Biosciences, Inc.FBRX - businesswire.com
Are SUNS, VREX, CHMI, FBRX Obtaining Fair Deals for their Shareholders? - Sahm
argenx (ENXTBR:ARGX) Is Considering A Forte Biosciences Acquisition - Yahoo Finance
Forte Biosciences Inc expected to post a loss of 88 cents a shareEarnings Preview - TradingView
FBRX Q2'26 Earnings: revenue estimate is 0 USD - TradingView
FBRX Stock Alert: Halper Sadeh LLC is Investigating Whether Forte Biosciences, Inc. is Obtaining a Fair Price for its Shareholders - FinancialContent
Janus Henderson Group Ltd. (NASDAQ: FBRX) discloses 2.5% beneficial stake in Forte - Stock Titan
Argenx Announces Commencement Of Tender Offer To Acquire Forte Biosciences, Inc. >ARGX.BT - Moomoo
argenx launches tender offer for Forte Biosciences at $77 per share - Investing.com
Forte Biosciences (NASDAQ:FBRX) Sees Large Volume IncreaseHere's Why - MarketBeat
Argenx Unit Launches Tender Offer to Acquire Forte Biosciences - marketscreener.com
Argenx Unit Kicks Off Tender Offer to Buy Forte Biosciences - marketscreener.com
argenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc. - GlobeNewswire
Forte Biosciences (FBRX) to Release Earnings on Thursday - MarketBeat
Weekly Recap: Argenx $2.2B buyout at $77 and FB102 84% response rate - TradingView
Janus Henderson Group PLC Reduces Stake in Forte Biosciences, Inc. $FBRX - marketbeat.com
Price to earnings forward of Forte Biosciences, Inc. – NASDAQ:FBRX - TradingView
Enterprise value to revenue forward of Forte Biosciences, Inc. – NASDAQ:FBRX - TradingView
argenx SE (ARGX) Forte Biosciences, Inc.M&A CallSlideshow (NASDAQ:ARGX) 2026-07-31 - Seeking Alpha
Forte Biosciences stock hits 52-week high at 76.69 USD By Investing.com - Investing.com Nigeria
Forte Biosciences stock hits 52-week high at 76.69 USD - Investing.com
Forte Biosciences (NASDAQ:FBRX) Stock Rating Lowered by Evercore - MarketBeat
Netherlands: argenx to acquire Forte Biosciences for US$2.2bn - Investors in Healthcare
Barclays cuts Forte Biosciences stock rating on acquisition terms By Investing.com - Investing.com Nigeria
argenx signs agreement to buy Forte Biosciences for $2.2bn - Yahoo Finance
Biotech Growth makes 14-times return on Forte Biosciences accepting $2.2bn bid from Argenx SE - QuotedData
Barclays cuts Forte Biosciences stock rating on acquisition terms - Investing.com
Forte Biosciences (FBRX) Stock Looks Stretched On Book Value Yet Strong On Pipeline Hope - simplywall.st
Biotech Growth Trust Notes $2.2 Billion Acquisition Of Forte Biosciences - DirectorsTalk Interviews
argenx acquires Forte Biosciences for FB102 - BioXconomy
Forte Biosciences Inc (FBRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Why Did AAPL, FBRX, RTX Stocks Surge To 52-Week Highs Today? - TradingView
Dallas biopharmaceutical company to be acquired for over $2B - Dallas News
Why is Forte Biosciences stock surging nearly 40% today? By Investing.com - Investing.com UK
Argenx enters biotech buyer class with $2.2B Forte takeout - BioCentury
argenx (FBRX counterparty) plans full-share tender offer for Forte Biosciences - Stock Titan
Argenx’s $2B Forte Bio Acquisition Brings Autoimmune Playbook to Prevalent Disorders - MedCity News
The $2.2 Billion Reason Forte BioSciences (FBRX) Stock Is Skyrocketing Today - Barchart.com
Firm Advises Forte Biosciences on $2.2 Billion Acquisition by argenx - Wilson Sonsini
Argenx to acquire Forte Biosciences for $2.2 billion - Drug Discovery News
Forte Biosciences agrees to $2.2 billion buyout - The Business Journals
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Forte Biosciences, Inc. (NASDAQ: FBRX) - Morningstar
Argenx to Acquire Forte Biosciences for $2.2 Billion, Bolstering Immunology Pipeline with Promising Anti-CD122 Antibody - finance.biggo.com
Shareholder Alert: Ademi LLP investigates whether Forte Biosciences, Inc. is obtaining a Fair Price for Public Shareholders - Morningstar
Forte: 'Hold' On Positive FB102 Vitiligo Treatment Data And argenx Acquisition For $2.2 Billion - Seeking Alpha
Argenx Buys Forte Biosciences for $2.2B to Boost Pipeline - Briefs Finance
Stocks making the biggest moves midday: ASML, SK Hynix, SAP, Forte Bio, Brown-Forman & more - CNBC
Argenx to buy Forte Biosciences for about $2.2 billion - 95.7 KELO-FM
1.80%
1.77%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):